Latest Abarceo Pharma News & Updates

See the latest news and media coverage for Abarceo Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Abarceo Pharma

Pre-clinical biotech developing mitochondrial dysfunction therapies

abarceo.com
Headquarters
Malmö, Sweden
Founded year
2017
Company type
Private company
Number of employees
2–10

Last updated

Latest news about Abarceo Pharma

In short: Abarceo Pharma presented data on its novel diabetes treatment and engaged with investors to discuss mitochondrial repair and insulin secretion.

Company announcements

  • Abarceo Pharma

    Abarceo attends ATTD conference

    From 11–14 March in Barcelona, Abarceo promotes its diabetes drug restoring insulin secretion, improving sensitivity via daily oral pill.

  • Abarceo Pharma

    Abarceo Pharma presents mitochondrial repair developments

    They focus on Type 1 Diabetes and anticipate partnering and finance discussions at a Nordic meeting.

  • Abarceo Pharma

    Abarceo Pharma presents novel diabetes treatment data

    Groundbreaking data on VDAC1 inhibitors is revealed at the 5th Swedish Diabetes Summit via poster by Ruchi Jain and Claes Wollheim.

  • Abarceo Pharma

    Abarceo Pharma gets Almi Invest as part-owner

    The company raises a total of 21.5 million kronor to develop drug candidates against type 2 diabetes.

Unlock all announcements with a

Media coverage

Be the first to know. to get notified the second Abarceo Pharma hits the news.

Never miss news about Abarceo Pharma

Track Abarceo Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Abarceo Pharma competitors & trending companies

Browse news for competitors to Abarceo Pharma and other trending companies.